TR03-002-EN

002 Jurkovic.p65

002 Nikoli..p65

!" ! #$ % &$ $!' ( " # )$!& * % & ! + , * # + # &! + !& , . / ) ) 0 )$ " !#$& * # ) " ( !& * % & ! ) , *! ) $ & ' (* 1 )' " . )$ 223 , * $3 #)$! 4 !' !$ ', # % 1 # " 1 $% % " & 4 $ " # )$!& 0& !' * ! * % & ! + , * # ! + # &! % # * % ( & % $ $5 . ) %6 " 1 $% % 5 #$ $ ' &' $ " # )$!& &$ , ( 5 ) % # !& ' , * # % 37 $8'& %$% % , * # ) !$ 1 #$ " !$1 ', % ) !& '& ) + ). 1 , & ) + 1 &$ ) 4 ) !' 4 # 4 ...

GCNU TR 1999 – 002 Linear

This note gives a closed form expression for the linear transform computed by an optimally trained linear heteroencoder network of arbitrary topology trained to minimize squared error. The transform can be thought of as a restricted rank version of the basic linear least-squares regression (discrete Wiener filter) between input and output. The rank restriction is set by the “bottleneck” size of...

P01-002 – Comparison between different colchicines responders

Results The study group comprised 221 FMF patients (116F, 105M) with a mean age of 12.7±5.3 years. Mean duration of colchicine use was 58.9±45.3 months. Patients were divided into two groups according to their colchicine response; Group I (n=131) included patients with no attacks after colchicine and Group II (n=90) patients with partial or no response to colchicine. Mean age, sex, age at disea...

OR6-002 – Thromboembolism in autoinflammatory syndromes

Methods The case records of patients with auto inflammatory syndrome were studied to assess history and site of VTE. Subtype of auto inflammatory disease was noted along with risk factors for VTE and therapy for auto inflammatory disease. In addition it was assessed if auto inflammatory disease had been clinically active at the time of VTE and whether inflammatory markers were elevated in the 6...